Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-DP20-002, Natural Experiments of the Impact of Population-Targeted Policies To Prevent Type 2 Diabetes and Diabetes Complications; Amended Notice of Meeting, 8593 [2020-03018]

Download as PDF Federal Register / Vol. 85, No. 31 / Friday, February 14, 2020 / Notices FEDERAL RESERVE SYSTEM DEPARTMENT OF HEALTH AND HUMAN SERVICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies Centers for Disease Control and Prevention The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than March 17, 2020. A. Federal Reserve Bank of Boston (Prabal Chakrabarti, Senior Vice President) 600 Atlantic Avenue, Boston, Massachusetts 02210–2204. Comments can also be sent electronically to BOS.SRC.Applications.Comments@ bos.frb.org: 1. HB Holdings, MHC, Haverhill, Massachusetts; to become a mutual bank holding company upon the conversion by Haverhill Bank, Haverhill, Massachusetts, from mutual to stock form. Board of Governors of the Federal Reserve System, February 11, 2020. Yao-Chin Chao, Assistant Secretary of the Board. khammond on DSKJM1Z7X2PROD with NOTICES [FR Doc. 2020–03029 Filed 2–13–20; 8:45 am] BILLING CODE P Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP20–002, Natural Experiments of the Impact of Population-Targeted Policies To Prevent Type 2 Diabetes and Diabetes Complications; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP20– 002, Natural Experiments of the Impact of Population-Targeted Policies To Prevent Type 2 Diabetes and Diabetes Complications; April 7–9, 2020; 10:00 a.m.–6:00 p.m., (EDT), Teleconference, which was published in the Federal Register on Friday, January 10, 2020, Volume 85, Number 7, pages 1316– 1317. The meeting is being amended to change the date and time to April 7–8, 2020, from 11:00 a.m.–6:00 p.m., EDT. The meeting is closed to the public. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–03018 Filed 2–13–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Announcement of Requirements and Registration for the 2020 Million Hearts Hypertension Control Challenge Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: VerDate Sep<11>2014 16:56 Feb 13, 2020 Jkt 250001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 ACTION: 8593 Notice. The Centers for Disease Control and Prevention (CDC) located within the Department of Health and Human Services (HHS) announces the launch of the 2020 Million Hearts Hypertension Control Challenge. DATES: The Challenge will accept applications from February 21, 2020 through April 6, 2020. FOR FURTHER INFORMATION CONTACT: Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop MS–S107–1, Chamblee, GA 30341, Telephone: 770–488–2424, Email: millionhearts@cdc.gov; subject line of email: Million Hearts Hypertension Control Challenge; Attention: Mary George. SUPPLEMENTARY INFORMATION: SUMMARY: Background Million Hearts is a national initiative to prevent one million heart attacks and strokes by 2022. In order to prevent one million cardiovascular events (e.g., heart attacks and strokes), we need to decrease smoking, sodium consumption and physical inactivity by 20%; improve performance on quality of care measures for appropriate aspirin use, blood pressure control, cholesterol management, and smoking cessation to 80%; and improve outcomes for priority populations disproportionately burdened by cardiovascular disease. Over the last six years, we have seen tremendous progress by providers and health care systems that focus on improving their performance in controlling patients’ blood pressure. Getting to 80% blood pressure control would mean that 10 million more Americans with hypertension would have their blood pressure under control, and be at substantially lower risk for strokes, heart attacks, kidney failure, and other related cardiovascular events. For more information about the initiative, visit https:// millionhearts.hhs.gov/. Million Hearts is a registered trademark of the Department of Health and Human Services. The challenge is an important way to call attention to the need for improved hypertension control, provides a powerful motivation and target for clinicians, and will improve understanding of successful implementation strategies at the health system level. It will identify clinicians, clinical practices, and health systems that have exceptional rates of E:\FR\FM\14FEN1.SGM 14FEN1

Agencies

[Federal Register Volume 85, Number 31 (Friday, February 14, 2020)]
[Notices]
[Page 8593]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03018]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--DP20-002, Natural Experiments of the Impact of 
Population-Targeted Policies To Prevent Type 2 Diabetes and Diabetes 
Complications; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--DP20-002, Natural Experiments of the Impact of Population-
Targeted Policies To Prevent Type 2 Diabetes and Diabetes 
Complications; April 7-9, 2020; 10:00 a.m.-6:00 p.m., (EDT), 
Teleconference, which was published in the Federal Register on Friday, 
January 10, 2020, Volume 85, Number 7, pages 1316-1317.
    The meeting is being amended to change the date and time to April 
7-8, 2020, from 11:00 a.m.-6:00 p.m., EDT.
    The meeting is closed to the public.
    For Further Information Contact: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-03018 Filed 2-13-20; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.